Edwards Lifesciences Corporation (EW) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 49.85B |
| Enterprise Value | 47.62B |
| P/E Ratio | 45.44 |
| PEG Ratio | -0.62 |
| Price/Sales Ratio | 7.84 |
| Price/Book Ratio | 4.82 |
| Enterprise/Revenue | 7.57 |
| Enterprise/EBITDA | 33.58 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.17 |
| Operating Margin | 0.28 |
| Return On Assets | 0.08 |
| Return On Equity | 0.11 |
| Revenue | 6.07B |
| Revenue/Share | 10.88 |
| Gross Profit | 4.74B |
| EBITDA | 1.43B |
| Net Income | 1.07B |
| Diluted EPS | 1.83 |
| Total Cash | 3.67B |
| Total Cash/Share | 6.34 |
| Total Debt | 702.9M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 4.42 |
| Book Value Per Share | 17.83 |
| 52-Week Change | 14.02 |
| 52-Week High | 89.6 |
| 52-Week Low | 72.3 |
| Moving Average 50 Days | 83.4 |
| Moving Average 200 Days | 81.98 |
| Average Volume | 5.09M |
| Shares Outstanding | 575.8M |
| % Held by Institutions | 86.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | June 01, 2020 |